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Abstract
Background: Mutations in the titin gene (TTN) cause a large spectrum of diseases affecting skeletal and/or cardiac
muscle. TTN includes 363 coding exons, a repeated region with a high degree of complexity, isoform-specific
elements, and metatranscript-only exons thought to be expressed only during fetal development. Although three
main classes of isoforms have been described so far, alternative splicing events (ASEs) in different tissues or in
different developmental and physiological states have been reported.
Methods: To achieve a comprehensive view of titin ASEs in adult human skeletal muscles, we performed a RNA-
Sequencing experiment on 42 human biopsies collected from 12 anatomically different skeletal muscles of 11
individuals without any skeletal-muscle disorders.
Results: We confirmed that the skeletal muscle N2A isoforms are highly prevalent, but we found an elevated
number of alternative splicing events, some at a very high level. These include previously unknown exon skipping
events and alternative 5′ and 3′ splice sites. Our data suggests the partial inclusion in the TTN transcript of some
metatranscript-only exons and the partial exclusion of canonical N2A exons.
Conclusions: This study provides an extensive picture of the complex TTN splicing pattern in human adult skeletal
muscle, which is crucial for a proper clinical interpretation of TTN variants.
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Background
The TTN gene encodes titin, a muscle protein spanning
from the Z-disk to the M-band within the sarcomere. The
genomic structure of TTN is quite remarkable. It contains
364 exons (363 coding exons plus the first non-coding
exon) and can theoretically generate more than one million
splice variants [1, 2]. It also has a large repeated region
with a high degree of complexity [1].
Titin isoforms have traditionally been classified in
three main categories based on the presence of the N2A
and N2B elements within the I-band region [3–5]. N2A
isoforms (mainly expressed in the skeletal muscles)
contain the N2A element, but not the cardiac-specific
N2B element. On the contrary, N2B isoforms only
include the cardiac-specific N2B element. N2BA
isoforms, expressed in the heart, include both the N2B
and N2A elements. N2A and N2BA isoforms also in-
clude additional exons, resulting in a higher number of
Ig and PEVK domains in the I-band region.
Two further isoforms, named Novex-1 and Novex-2, are
very similar to N2B but each of them includes an isoform-
specific exon (exon 45 and exon 46, respectively). Finally,
the Novex-3 isoform only contains the N-terminal part of
titin due to an alternative stop codon in the Novex-3-
specific exon 48.
Interestingly, specific exons included in the inferred
complete metatranscript (NM_001267550.1) and referred
to as metatranscript-only or meta-only exons are thought
to be expressed only during embryonic development.
Thereafter, they are not included in the canonical soleus-
derived N2A skeletal muscle isoform, or in any of the five
cardiac isoforms.
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An extensive use of alternative splicing (AS) in differ-
ent tissues or in different developmental and physio-
logical states has been reported, resulting in a longer or
smaller protein [2]. This reflects the global massive use
of tissue-specific AS events (ASEs) which have been de-
scribed in the skeletal muscle [6, 7].
Although the presence of multiple different transcripts
originating from TTN gene as consequence of ASEs has
been partly suggested by experimental evidence [1, 2, 8], we
still lack a clear picture of the global exon usage and of the
subsequent splicing profile of TTN muscular transcripts.
The introduction of RNA sequencing (RNA-Seq) methods
has enabled a comprehensive study of the transcriptome [9].
Although early work focused on gene-expression analyses,
RNA-Seq is a powerful tool for the identification and the
study of alternative exon and splice site usage and of novel
isoforms. It also allows an accurate quantification of relative
transcript abundances [6, 10].
In this study, we analyzed RNA sequencing data of hu-
man adult skeletal muscle tissues to obtain a comprehen-
sive view of titin ASEs. This is crucial for a proper clinical
interpretation of TTN variants that have been associated
with a wide spectrum of human diseases and for an im-
proved genotype-phenotype correlation [11–16].
Methods
Skeletal muscle samples and RNA extraction
Data was generated using 42 human skeletal muscle
samples dissected from 12 anatomically different skel-
etal muscles (tibialis anterior, flexor hallucis longus,
soleus, extensor digitorum longus, gracilis, semitendi-
nosus, semimembranosus, vastus medialis, vastus later-
alis, sartorius, biceps femoris, adductor magnus)
collected from 11 adult individuals (7 males and 4 fe-
males) who had undergone above or below-the-knee
amputation surgery for medical reasons other than
neuromuscular disorders (Additional file 1:Table S1).
A written informed consent was signed by all the pa-
tients and the Tampere University Hospital (Tampere,
Finland) Ethics Committee approved the study.
The samples (5 × 5 mm of size) were processed im-
mediately after their removal to avoid tissue degrad-
ation as previously described [17]. Total RNA was
extracted from the selected samples by the TRIzol re-
agent method, according to the manufacturer’s in-
structions (Invitrogen, Life Technologies, Canada).
RNA quality was checked with BioAnalyzer equip-
ment using the RNA 6000 Nano Assay kit (Agilent
Technologies, CA, USA).
Library preparation, sequencing, and bioinformatics
Indexed sequencing libraries were generated from 1 μg
of total RNA, using the TruSeq Stranded Total RNA kit
according to the manufacturer’s instructions (Illumina,
CA, USA). Single-end sequencing (86 bp reads) of
multiplex libraries was performed on NextSeq500 in-
strument. Raw reads were mapped against the hg19 hu-
man reference genome using TopHat2 [18]. TopHat
was also used for detecting and counting exon junc-
tions. Alternative splice sites were evaluated using Hu-
man Splicing Finder (HSF) program [19].
For each exon, the inclusion rate was calculated as
[(I/2)/[(I/2) + E], where I is the number of reads sup-
porting the exon inclusion (all junctions going into
and exiting the exon) and E is the number of reads
supporting its exclusion.
Experimental validation of alternative splicing events
For experimental validation of RNA-Seq results, cDNA
synthesis was performed using SuperScript III First-Strand
Synthesis System (Thermo Scientific, USA). RT-PCRs
were performed using 1 μl of cDNA and a DreamTaq™
DNA Polymerase (Thermo Scientific). Primers were de-
signed with Primer3 software (sequences available upon
request). Amplified products were separated on 2% agar-
ose gels and specific electrophoresis bands, corresponding
to differently spliced products, were extracted using
NucleoSpin Gel and PCR Clean-up (Macherey-Nagel,
Germany) and analyzed by Sanger sequencing.
Publicly available data
We also evaluated the presence of the ASEs in publicly
available total mRNA sequencing data of adult gastrocne-
mius medialis from the ENCODE project (https://www.en-
codeproject.org; accession numbers ENCFF219LYV,
ENCFF308RYZ, ENCFF569TCU, ENCFF408QZN, and
ENCFF064NBB). Junctions were extracted from the avail-
able bam-files using regtools (https://github.com/griffith-
lab/regtools).
Similarly, we analyzed RNA-Seq data from fetal skel-
etal muscles (accession numbers ENCFF009MKH,
ENCFF084FDS, ENCFF121PKV, and ENCFF405BHX),
fetal heart (accession numbers ENCFF111DKK,
ENCFF686KAP, ENCFF167WVS, and ENCFF174EGJ),
and adult heart (accession numbers ENCFF735RZM,
ENCFF834OIQ, ENCFF608FZD, and ENCFF621SXE)
from ENCODE.
Results
Before focusing on alternative splice events, we analyzed
the canonical junctions, which are present in the previ-
ously reported isoforms, to evaluate their relative expres-
sion in human adult skeletal muscles. As expected, the
junction 47–50, uniquely present in the previously iden-
tified skeletal long isoform N2A [1], is detected at very
high level in all our samples (Fig. 1a). This confirms that
most of the skeletal muscle transcripts belong to this
class of isoforms.
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We then calculated the number of reads supporting
each of the N2A canonical splicing events (Additional file 2:
Table S2). Most of the canonical N2A junctions were
identified. Interestingly, we noticed a very low number of
reads supporting the inclusion of exon 11 (junctions link-
ing exon 10–11 and exon 11–12). Similarly, we did not
observe reads connecting exons 183 and 203.
Then, we proceeded to the analysis of the alternative
splice events. We identified 4039 unique splicing events,
most of them in one or a few samples and supported by a
very low number of reads. In order to eliminate the back-
ground sequencing noise and/or very weakly expressed
transcripts, we applied a stringent quality control (QC)-fil-
tering process, prioritizing only splicing events (n = 498)
supported by at least 1000 reads and identified in at least
14 samples. To reduce possible artefacts due to technical is-
sues and obtain a less biased splicing pattern, we analyzed
publicly available total mRNA sequencing data of adult
gastrocnemius medialis from the ENCODE project. In a
very conservative approach, we only focused on splicing
events identified in our experimental samples as well as in
the publicly available data (> 10 reads in ENCODE data).
After that, we proceeded with a multistep analysis,
based on two different categories of splicing events: (1)
ASEs involving canonical splice sites (out of the repeated
region and within this area) and (2) ASEs involving alter-
native splicing sites.
1) We identified 46 unreported exon junctions,
involving canonical splice sites out of the repeated
region (Table 1). All these 46 ASEs are predicted to
maintain the frame. For 23 ASEs, we performed RT-
PCR and all confirmed the RNA-Seq results.
We identified three ASEs (10–12; 10–13; 10–14),
suggesting the skipping of exon 11. In line with the
RNA-Seq results, RT-PCR confirms that exon 11
was poorly expressed in human adult skeletal muscle
(Fig. 1b).
Interestingly, 24 unreported junctions span meta-
only exons, suggesting their partial inclusion in TTN
human adult skeletal muscle transcripts (Table 1
and Fig. 1c).
We identified a high number of reads involving the
canonical splice sites of exons included in the
a
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Fig. 1 Isoform identification and titin alternative splicing events in human skeletal muscle. a The previously reported classes of isoforms differ
from each other by the inclusion/exclusion of exons 48 (included only in Novex3 isoform) and 49 (included in all the other isoforms except the
long skeletal muscle N2A-isoform). Our data suggests that N2A isoform is 20 times more expressed than Novex3. All the other isoforms have a
very low expression. b We identified a low number of reads connecting exon 11 to its flanking exons. On the contrary, a high number of reads
connect exon 10 to exon 12 and 13, thereby skipping exon 11. In line with the RNA-Seq results, a standard RT-PCR (forward primer on exon 9
and reverse primer on exon 13, red arrows) and agarose gel electrophoresis show a very low abundance of the transcript including exon 11. M1
= 100 bp ladder. c Several RT-PCRs and agarose gel electrophoresis show a variable expression of metatranscript-only exons, confirming the RNA-
Seq results. In particular, no expression of exons 163 and 165 is detected; on the contrary, all the other RT-PCRs result in a detectable band
corresponding to the expected size. M1 = 100 bp ladder; M2 = 1 kb ladder; d = PCR from a control DNA; c = RT-PCR from a control cDNA
(obtained by a retrotranscription of RNA extracted from gracilis muscle). d Titin repeated region is composed of nine exons/blocks (here
represented by different colors and named B1-B9) repeated three times. Within the repeated region, linear expression of consecutive exons has
been detected. Moreover, a number of alternative splicing events has been identified. e We detected alternative splicing acceptors or donors
leading to subtle changes in the produced protein. The splice-site strength for canonical splice sites (5′ss and 3′ss) as well as for alternative sites
(alt 5′ss, alt 3′ss) has been calculated by Human Splice Finder (HSF)
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repeated area (Additional file 3: Supplementary
Material 1, Additional file 4: Table S3 and
Additional file 5: Table S4). Well-known bias due to
such repetitive regions hampers a comprehensive
and accurate study of this region. However, our data
suggests the linear expression of consecutive exons
within this area. We also identified a number of
ASEs linking non-consecutive exons within the
repeated elements (Fig. 1d).
2) We observed the usage of alternative splice sites
(acceptors or donors) located next to the canonical
sites. Most of these alternative splice sites (16/19)
would produce an in-frame insertion or deletion of a
few amino acids. The Human Splicing Finder (HSF)
program displayed high splice site scores for most of
these alternative splice sites, further suggesting their
real use in TTN transcripts (Table 2 and Fig. 1e).
Based on the aforementioned splicing events passing
our stringent QC filters, we calculated for each of the
coding exons showing an alternative splicing, and not in-
cluded in the repeated region, the number of reads sup-
porting their inclusion or exclusion in TTN transcripts
and a subsequent inclusion value (Table 3). It is note-
worthy that 13 meta-only exons are expressed but only 7
have an inclusion value higher than 10%. On the other
side, most of the canonical N2A exons, reported to be
expressed in adult skeletal muscle, have a high inclusion
value. Exon 11 as well as exons 155, 156, and 157 have
an inclusion value lower than 50%, indicating that they
are mostly spliced out.
To evaluate the spatial and temporal expression of
exon 11 and of meta-only exons, we examined a subset
of publicly available RNA-Seq data from fetal skeletal
muscles and fetal and adult hearts (Fig. 2). Interestingly,
exon 11 is mostly expressed in fetal and adult hearts. Its
expression is very low in adult and fetal skeletal muscles.
Exon 148 has a similar expression in fetal and adult
muscles, and it is mostly skipped in fetal and adult
hearts. On the contrary, meta-only exons 213–217 are
almost constitutively expressed in fetal muscles and their
expression is halved in adult muscles.
Table 1 Previously unreported junctions involving canonical
splice sites out of the repeated region
Donor exon Acceptor exon #TotReads #TotReads encode
10 12 63,681 31,420
10 13 37,864 22,425
10 14 25,860 19,371
36 38 2848 46
51 54 2319 52
85 88 8333 113
112 114 10,267 45
116 119 8651 1859
132 134 16,926 2843
137 143 1865 700
144 146 8300 297
146 151 10,262 805
146 152 3145 778
147 148 32,429 26,174
148 149 26,771 12,941
149 150 1304 951
150 151 1857 2836
153 158 12,300 116
154 158 35,902 4086
158 159 28,020 13,261
158 167 1129 45
158 168 3759 56
158 171 2965 279
158 172 7567 991
159 167 3117 2355
159 168 3192 1137
159 171 3722 3283
159 172 3627 1620
167 168 1830 2517
168 169 8111 7411
169 170 5910 5129
170 171 3237 8145
171 172 1439 8414
202 203 1358 15,787
203 209 1463 14
208 210 1741 27
212 213 28,311 11,949
213 214 8695 17,192
214 215 13,360 12,752
215 216 14,850 18,391
215 217 1647 1208
216 217 11,704 7775
Table 1 Previously unreported junctions involving canonical
splice sites out of the repeated region (Continued)
Donor exon Acceptor exon #TotReads #TotReads encode
217 218 10,983 15,909
219 222 1146 333
224 226 3126 2401
362 364 5458 2555
Metatranscript-only exons in italics
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A list of all detected ASEs that did not reach the mini-
mum filtering criteria (i.e., a minimum of 14 out of 42
samples analyzed and at least 1000 supporting reads in
total) or were not identified in the publicly available
ENCODE data is included in Additional file 6: Table S5.
Discussion
Recent mRNA-Seq transcriptomic analyses show that
most of multi-exonic genes are alternatively spliced [7,
10, 20]. In particular, a vast majority of ASEs are tissue
specific [10], and skeletal muscle seems to be among the
tissues showing the highest numbers of tissue-specific
ASEs [6, 7, 20].
Considering its 363 coding-exons and its genetic
organization, a large number of ASEs were expected and
partly reported in TTN transcripts. However, previous data,
obtained by using different heterogeneous strategies in a
pre-NGS era, did not provide a comprehensive view of the
TTN splicing pattern and neither any unbiased repertoire
of TTN ASEs in human adult skeletal muscles [1, 2, 8].
In our study, by performing RNA-Seq analysis using
42 adult human skeletal muscle samples, we identified in
a reliable way a large number of ASEs, some of them at
a very high level.
We detected previously undescribed exon-exon junc-
tions, suggesting novel, unreported skipping events. Exon
11, included in the canonical adult skeletal muscle isoform
N2A, is mostly skipped in adult skeletal muscles. On the
contrary, most of the so-called metatranscript-only exons
are expressed in adult skeletal muscle at a variable level.
Moreover, we identified alternative acceptors and donors
leading to subtle changes in the produced protein. Al-
though these events need to be experimentally validated,
similar ASEs have already been described in other human
genes and their functional relevance has been hypothesized
[21–23].
With the exception of exon 11, the N-terminal exons,
coding for the Z-disk part of titin, are mostly constitu-
tively expressed. Exons 8 to 14 encode for seven copies
of a specific domain, named Z-repeat (Zr) [24]. In par-
ticular, exon 11 encodes for Z-repeat 4 [24], and its dif-
ferential splicing has been previously reported [25].
Sorimachi and colleagues reported that Z-repeats 1, 2, 3,
and 7 are expressed in all striated rabbit muscles,
whereas the expression of Zr4, 5, 6 (corresponding to
exons 11–12 and 13) is dependent on developmental
stage and tissue-type [25]. The differential splicing of the
titin Z-disk seems to be part of a larger and more com-
plex process able to modulate Z-disk interactions via
Table 2 List of events involving alternative splice sites
Donor Acceptor #Samples #Reads Frame HSF consensus value
novel donor splice
site (value for wt)
HSF consensus value
novel acceptor splice
site (value for wt)
#Reads encode
c.669 (ex5) c.673 (ex6-alt acc) 31 1195 Yes – 78.86 (85.41) 287
c.1398 (ex8) c.1399–3 (int8-alt acc) 42 6992 Yes – 73.1 (80.21) 4456
c.9471 (ex40) c.9508 (ex41-alt acc) 19 10,437 Yes – 76.95 (90.97) 101
c.22528 (ex78) c.22871 (ex80-alt acc) 27 1287 Yes – Unpredicted
(77.00)
198
c.29124 (ex102-alt don) c.29228 (ex103-alt acc) 31 3807 No Unpredicted (88.47) 72.03 (79.27) 20
c.30754 (ex113) c.30757 (ex114-alt acc) 16 1537 No – 72.87 (85.71) 15
c.31426 (ex118) c.31433 (ex119-alt acc) 31 4960 Yes – 79.99 (81.96) 35
c.31762 (ex122) c.31769 (ex123-alt acc) 19 3455 Yes – 86.28 (67.88) 33
c.32197 (ex127) c.32207 (ex128-alt acc) 25 1018 Yes – 82.28 (78.21) 44
c.32392 (ex129) c.32399 (ex130-alt acc) 41 5055 Yes – 82.29 (75.58) 121
c.33910 (ex145) c.33917 (ex146-alt acc) 18 1733 Yes – 80.36 (77.55) 25
c.33994 (ex146) c.34301 (ex148-alt acc) 19 12,820 Yes – 72.21 (73.01) 159
c.38058 (ex191-alt don) c.39484 (ex208-alt acc) 37 1038 Yes Unpredicted (76.37) 74.68 (80.08) 32
c.38058 (ex191-alt don) c.38980 (ex202-alt acc) 37 1427 Yes Unpredicted (76.37) 75.98 (77.27) 26
c.39063 (ex203-alt don) c.39484 (ex208-alt acc) 35 2300 Yes Unpredicted (77.92) 74.68 (80.08) 29
c.39147 (ex204-alt don) c.39484 (ex208-alt acc) 41 4744 Yes Unpredicted (76.37) 74.68 (80.08) 105
c.40786 (ex223) c.40790 (ex224 - alt acc) 30 1518 Yes – 75.32 (94.42) 257
c.40876 (ex224) c.40880 (ex225 - alt acc) 24 1635 Yes – 77.2 (91.6) 151
c.44646 (ex243-alt don) c.44914 (ex245) 20 10,706 No 83.39 (82.15) – 15
alt don alternative donor, alt acc alternative acceptor
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Table 3 Exon usage
Exon(s) Inclusion
rate
#Inclusion
reads
#Exclusion
reads
Skipping
event
ex1-10 Constitutively expressed
ex11 Constitutively spliced out
ex12 54% 147,944 63,724 10–13;10–14
ex13 79% 194,924 25,860 10–14
ex14–
36
Constitutively expressed
ex37 98% 335,403 2848 36–38
ex38–
44
Constitutively expressed
ex45–
46
Constitutively spliced out
ex47 Constitutively expressed
ex48 2% 5526 132,355 47–50
ex49 Constitutively spliced out
ex50–
51
Constitutively expressed
ex52 98% 222,051 2319 51–54
ex53 98% 252,059
ex54-
ex78
Constitutively expressed
ex79 99% 262,245 1287 c.22,528–22,871
ex80–
85
Constitutively expressed
ex86 91% 174,217 8333 85–88
ex87 93% 216,577
ex88–
112
Constitutively expressed
ex113 90% 187,870 10,267 112–114
ex114-
116
Constitutively expressed
ex117 92% 200,426 8651 116–119
ex118 92% 209,844
ex119-
132
Constitutively expressed
ex133 66% 66,307 16,926 132–134
ex134–
137
Constitutively expressed
ex138 97% 143,120 1865 137–143
ex139 96% 86,065
ex140 95% 77,132
ex141 96% 97,228
ex142 96% 100,706
ex143–
144
Constitutively expressed
ex145 83% 82,433 8300 144–146
ex146 Constitutively expressed
ex147 62% 86,205 26,227 c.33994–34,301;146–
151;146–152
Table 3 Exon usage (Continued)
Exon(s) Inclusion
rate
#Inclusion
reads
#Exclusion
reads
Skipping
event
ex148 68% 72,020 16,913 146–151;146–152;147–149
ex149 67% 53,414 13,407 146–151;146–152
ex150 4% 3161 35,240 146–151;146–152;149–151
ex151 94% 94,107 3145 146–152
ex152–
153
Constitutively expressed
ex154 82% 115,379 12,300 153–158
ex155 35% 52,812 48,202 153–158;154–158
ex156 34% 49,216
ex157 40% 64,075
ex158 Constitutively expressed
ex 159 20% 52,844 103,121 158–167;158–168;158–
171;158–172;158–173;
158–175;158–182;158–
184;158–191;158–193;
158–204
ex160-
ex166
Constitutively spliced out
ex 167 2% 6076 123,699 158–168;158–171;158–
172;158–173;158–175;158–
182;158–184;158–191;158–
193;158–204;159–168;159–
171;159–172;159–173;159–
175;159–184;159–193
ex 168 7% 16,892 116,748 158–171;158–172;158–
173;158–175;158–182;158–
184;158–191;158–193;158–
204;159–168;159–171;159–
172;159–173;159–175;159–
184;159–193
ex 169 6% 14,021
ex 170 4% 9147
ex 171 5% 11,363 110,061 158–172;158–173;158–
175;158–182;158–184;158–
191;158–193;158–204;159–
172;159–173;159–175;159–
184;159–193
ex172-
205
Repeated region
ex206 81% 184,735 21,799 175–209;184–209;c.38058-
c.39484;193–209;c.39063-
c.39484;203–209;c.39147-
c.39484
ex207 68% 91,407
ex208 76% 86,726 13,717 175–209;184–209;193–
209;203–209
ex209 97% 99,982 1741 208–210
ex210–
212
Constitutively expressed
ex213 26% 37,006 53,547 212–218
ex214 17% 22,055
ex215 22% 29,857
ex216 19% 26,554 55,194 212–218;215–217
ex217 19% 24,334 53,547 212–218
ex218-
ex219
Constitutively expressed
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splicing regulation. The N-terminal Z-disk region of titin
binds a number of proteins, including alpha-actinin,
nebulin, and filamin C that undergo a similar process of
differential splicing [26–28].
As expected, most of the ASEs occur in the I-band re-
gion of titin, where a large number of exons are alterna-
tively spliced [3, 4]. It is noteworthy that exon 148,
thought to be a meta-only exon, has an inclusion rate
comparable to that of its neighboring exons in both adult
and fetal skeletal muscles. Moreover, our experimental
data as well as publicly available data suggests a significant
expression of the meta-only exons 213, 214, 215, 216, and
217 in adult skeletal muscle, although their inclusion is
higher in fetal muscles. In the M-band, we identified the
previously reported splicing event (skipping of exon 363),
producing the so called is7– and is7+ isoforms [29, 30]. In
line with previous data, exon 363 is skipped in about 10%
of TTN transcripts in human adult skeletal muscle.
As already discussed for the Z-disk splicing events, the
regulation of alternative splicing events probably corre-
sponds to modulation of interaction networks. For example,
it is well known that the alternatively spliced is7 region,
encoded by exon 363, binds the calcium-dependent prote-
ase calpain 3 (CAPN3) [31]. On the other hand, the role of
the titin, and also nebulin, filament length (as a result of
splicing events) on the sarcomere length and its passive
elastic properties is still under debate [32–34].
Mutations in the TTN gene cause several different and
heterogeneous skeletal muscle disorders with or without
cardiac involvement, characterized by a variability in the
age of onset, muscle involvement, and disease-course
[11, 12, 35]. In addition, truncating mutations (TTNtv)
have been associated with dilated cardiomyopathy
(DCM) [13, 14]. A genotype–phenotype correlation has
been observed to some extent [11, 15]. Mutations in
metatranscript-only exons have recently been associated
with a congenital titinopathy, characterized by arthrogry-
posis multiplex congenita and severe axial hypotonia as
a form of congenital amyoplasia without cardiac involve-
ment [36]. The hypothesis is that metatranscript-only
mutations (mostly truncating mutations) specifically and
selectively affect developmental isoforms, leading to a
Fig. 2 Comparison of alternative splicing events among different tissues at different developmental stages. The analysis of publicly available total
mRNA sequencing data from the ENCODE project shows that exon 11 is expressed only in cardiac muscles, whereas the expression of exon 148
is limited to skeletal muscles. Exons 213 and 217 show an increased expression in fetal skeletal (and, at least in part, cardiac) muscle compared to
the adult expression. The reported values correspond to the inclusion values, based on the number of reads supporting each exon inclusion or
exclusion in TTN transcripts
Table 3 Exon usage (Continued)
Exon(s) Inclusion
rate
#Inclusion
reads
#Exclusion
reads
Skipping
event
ex220 99% 168,189 1146 219–222
ex221 99% 194,654
ex222-
224
Constitutively expressed
ex225 95% 124,798 3126 224–226
ex226-
243
Constitutively expressed
ex244 93% 285,487 10,706 c.44,646–44,914
ex245-
362
Constitutively expressed
ex363 91% 115,672 5458 362–364
ex364 Constitutively expressed
Metatranscript-only exons in italics
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prenatal or congenital phenotype with a stable postnatal
disease-course or weakness amelioration. On the con-
trary, proximal truncating mutations in canonical exons
expressed on both alleles in adult isoforms lead to a pre-
mature truncated protein with nonsense mediated decay
and would probably cause fetal death. The pathogenesis
of TTNtv-related cardiomyopathies is probably more un-
clear; their penetrance is markedly reduced and they
show a positional effect [14]. In particular, only TTNtv
occurring in constitutive exons are significantly associ-
ated with DCM [14].
Deciphering the effective expression pattern of each
TTN-exon, including meta-only exons, is crucial for a
better understanding of TTN-related disorders. Our data
clearly shows a variable expression for most of the meta-
only exons (148, 150, 159, 167–171, 213–217), confirm-
ing, however, that some of them (160–166) are not
expressed at all in human adult skeletal muscles. Our
findings suggest the need for a more careful interpret-
ation of the variants identified in a clinical setting.
Here, we provided an accurate inventory of ASEs in
human adult skeletal muscles, which suggest the presence
of a high number of undescribed isoforms. Moreover, taking
into account all the alternative splicing events occurring in
TTN, we calculated a reliable inclusion value for titin exons.
Further work remains to be done in order to refine
our results. Long-read sequencing technologies, for ex-
ample, will allow the identification of multiple splicing
events along the same molecule, thereby elucidating
how the individual splice events here described are con-
nected, and thus confirming the presence of unreported
isoforms. Similarly, a larger number of samples from
each skeletal muscle type has to be analyzed in order to
identify muscle-type specific ASEs or splicing patterns,
considering that the current experimental setting has
not identified any clear splicing difference among the
muscles analyzed (Additional file 7: Table S6).
The exonic usage and the subsequent isoform expres-
sion seem to be finely regulated among different devel-
opmental and physiological and/or pathological states
[2, 17, 37]. A further refinement of TTN expression pro-
filing in different tissues and/or different physiological and
pathological states (including regenerating or injured mus-
cles) would be of a great clinical relevance, deepening, for
example, our understanding of the role of TTN variants in
complex human diseases.
Conclusions
We have identified and partly characterized a large num-
ber of alternative splicing events in titin, providing the
first RNA-Seq-based, accurate and comprehensive pic-
ture of TTN splicing pattern in adult human skeletal
muscle. This same approach will probably unveil similar
complex splicing patterns for other muscle transcripts.
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